Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:586-587 (15 March), doi:10.1136/bmj.39512.672743.94
Rebecca Coombes, freelance journalist
1 London
rcoombes@bmj.com
Howard Cedar got sucked into genetics research when it was still in its infancy. He talks to Rebecca Coombes about the breathtaking progress in cancer diagnosis and treatment and current barriers to further advances
| The first 150 words of the full text of this article appear below. |
Despite his emigration to Israel more than 30 years ago, Howard Cedars voice betrays his New York roots. A senior figure in genetics research, the Hebrew University professor is well placed to give a snapshot of current progress in this complex field, especially its application to cancer. He was an early pioneer in molecular biology, which "started a new era in medicine," he says. Instead of looking just at symptoms, molecular biology delves into the functions of the body and discovers the basis of disease.
Learning how genes are regulated has been long, slow work, and only now, after 25 years, is Cedar seeing the practical application of what he has been studying. Today, he talks about the "unbelievable" pace of genetic research. He is absolutely clear about the direction of travel for basic research to uncover the causes of disease but is frank about the "road blocks" in the
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.